These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
481 related items for PubMed ID: 3152618
1. Effects of glyburide treatment on serum lipoprotein and apolipoprotein concentrations and ratios in non-insulin-dependent diabetes mellitus. Waysbort J, Regitz G, Brunner D. Clin Ther; 1988; 10(4):392-400. PubMed ID: 3152618 [Abstract] [Full Text] [Related]
2. Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus. Waysbort J, Regitz G, Chaimowitz D, Tuval M, Nakash I, Brunner D. Clin Ther; 1988; 10(4):358-71. PubMed ID: 2978874 [Abstract] [Full Text] [Related]
3. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies. Hayashi T, Hirano T, Yamamoto T, Ito Y, Adachi M. Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958 [Abstract] [Full Text] [Related]
4. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy. Habib SS, Aslam M, Naveed AK, Razi MS. Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671 [Abstract] [Full Text] [Related]
5. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia. Saku K, Sasaki J, Arakawa K. Clin Ther; 1989 Feb; 11(2):247-57. PubMed ID: 2736571 [Abstract] [Full Text] [Related]
6. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance. Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S. Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465 [Abstract] [Full Text] [Related]
7. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial. Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW, Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group. Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001 [Abstract] [Full Text] [Related]
8. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait. Al-Rashidi M, Hussain AA, Nampoory MR, Al-Ali JH, Akanji AO. Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883 [Abstract] [Full Text] [Related]
9. Lipid profile and its relation to fasting insulin level in non-insulin dependent diabetes mellitus (NIDDM). Uddin F, Miah AK. Bangladesh Med Res Counc Bull; 1995 Aug; 21(2):64-72. PubMed ID: 8815864 [Abstract] [Full Text] [Related]
10. Serum lipids and apolipoproteins in relation to glycaemic control and diabetic nephropathy in long-term survivors of diabetes: results of the Erfurt Study. Schauer UJ, Pissarek D, Lundershausen R, Rühling K, Winkler L, Panzram G. Exp Clin Endocrinol; 1988 Mar; 92(3):280-6. PubMed ID: 3267003 [Abstract] [Full Text] [Related]
11. [Effects of high-carbohydrate/low-fat diet on serum lipid ratios in healthy young subjects]. Gan CF, Gong RR, Lin J, Li ZK, Tang H, Huang X, Li RH, Fang DZ. Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 39(2):267-71, 275. PubMed ID: 18630700 [Abstract] [Full Text] [Related]
12. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Yilmaz M, Biri A, Bukan N, Karakoç A, Sancak B, Törüner F, Paşaoğlu H. Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370 [Abstract] [Full Text] [Related]
13. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Langsted A, Freiberg JJ, Nordestgaard BG. Circulation; 2008 Nov 11; 118(20):2047-56. PubMed ID: 18955664 [Abstract] [Full Text] [Related]
14. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins. Kanbay M, Delibasi T, Kaya A, Aydogan T, Koca C, Akcay A, Duranay M, Yigitoglu R. Ren Fail; 2006 Nov 11; 28(7):567-71. PubMed ID: 17050239 [Abstract] [Full Text] [Related]
15. Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients. Ybarra J, James RW, Makoundou V, Bioletto S, Golay A. Diabetes Metab; 2001 Dec 11; 27(6):701-8. PubMed ID: 11852380 [Abstract] [Full Text] [Related]
16. Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein. Kappelle PJ, Zwang L, Huisman MV, Banga JD, Sluiter WJ, Dallinga-Thie GM, Dullaart RP. Expert Opin Ther Targets; 2009 Jul 11; 13(7):743-51. PubMed ID: 19505224 [Abstract] [Full Text] [Related]
17. [Postprandial changes of blood lipid after ordinary Chinese diet and the influencing factors thereof]. Fu ZF, Liu ML. Zhonghua Yi Xue Za Zhi; 2009 Feb 03; 89(4):260-2. PubMed ID: 19552844 [Abstract] [Full Text] [Related]